Quantcast

Latest Diagnostic tests Stories

2009-11-18 06:05:00

BRENTWOOD, Tenn., Nov. 18 /PRNewswire/ -- With workers' compensation diagnostic imaging charges totaling billions of dollars a year, more employers are looking for ways to control the cost of on-the-job injuries while ensuring that employees return to work quickly and safely. ADIN Healthcare, Inc. offers solutions to employers with a national network of diagnostic providers, evidence-based guidelines and process oriented service delivery. In conjunction with one of its major payers,...

2009-11-09 15:00:00

SAN DIEGO, Nov. 9 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today reported its financial results for the quarter ended September 30, 2009. (Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO) Third Quarter Results Total revenue for the third quarter of 2009 was $9.2 million, compared with $11.6 million for the third quarter of 2008. Cost of product and service revenue for the third quarter of 2009 was $2.7 million, compared with $4.5 million for the third quarter...

2009-11-02 14:44:00

SILVER SPRING, Md., Nov. 2 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today published a guidance document that should help manufacturers develop diagnostic tests for the 2009 H1N1 influenza virus. Although there are not any FDA-approved or cleared tests that diagnose this specific infection, during this pandemic manufacturers can submit a request to the FDA for an Emergency Use Authorization (EUA). If granted, the EUA will allow the test to be used during the national...

2009-10-29 12:51:00

NEW YORK, Oct. 29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Molecular Diagnostics: A Dynamic and Rapidly Broadening Market http://www.reportlinker.com/p0156566/Molecular-Diagnostics-A-Dynamic-and-Rapidly-Broadening-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire Molecular diagnostic applications in the areas of oncology, personalized medicine, inherited disorders, prediction of genetic...

2009-10-08 11:49:00

NEW YORK, Oct. 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets http://www.reportlinker.com/p0154011/Reportlinker-Adds-The-Market-for-Wellness-Programs-and-Their-Impact-on-Pharmaceutical-Diagnostic-and-Device-Product-Markets.html At their most basic level, wellness programs represent an attempt to...

2009-09-28 15:02:00

SAN DIEGO, Sept. 28 /PRNewswire-FirstCall/ -- SEQUENOM, Inc. (Nasdaq: SQNM) today announced the completion of the independent investigation by a special committee of independent directors related to the test data and results for the company's noninvasive prenatal test for Trisomy 21 (Down syndrome). The independent counsel engaged by the special committee interviewed over 40 witnesses and reviewed over 300,000 documents and emails. (Logo:...

2009-09-14 15:01:00

Ticker Symbol: CUR - U.S. Clinical Trial of the PCA3 Test Started - QUEBEC CITY, Sept. 14 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced revenue of $396,468 and a net loss of $4,034,364 or $0.09 per share for the third quarter ending July 31, 2009. The net loss in this quarter reflects in part activities initiated to promote the Previstage(TM)...

2009-09-02 12:00:00

HAYWARD, Calif., Sept. 2 /PRNewswire/ -- Advanced Cell Diagnostics, Inc. (ACD), announced today that it has completed the second closing of its Series A equity financing from Morningside Ventures, bringing the total capital raised in this round to $5.4 million. ACD will use the funds to accelerate the development of its proprietary diagnostic tests based on the company's patent pending RNAscope(TM) technology. "This second closing marks the achievement of our RNAscope(TM) technology...

4f3f4dc6c3ba3a1da08d6fea8c1d5c3b1
2009-07-04 09:00:00

The newest revolution in microbiology testing walks on four legs and says "baa."It's the hair sheep, a less-hirsute version of the familiar woolly barnyard resident. A new study from the Stanford University School of Medicine, which is to be published July 3 in PLoS ONE, finds that not only are these ruminants low-maintenance and parasite-resistant, they're also perfect blood donors for the microbiology tests necessary to diagnose infectious disease in the developing world.Identifying...

2009-06-22 09:00:00

BERLIN, NIMES, France and RICHMOND, Calif., June 22 /PRNewswire/ -- BRAHMS Aktiengesellschaft, a global diagnostics company, Cezanne, and Lumiphore Inc., a biotechnology leader in new proprietary fluorescent metal-lanthanide technology for use in high-value applications, announced that they have signed an agreement on incorporation of Lumiphore's Lumi4(R)-Tb complexes in BRAHMS diagnostic tests. Under the agreement, BRAHMS together with its subsidiary Cezanne, developer and manufacturer of...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related